49 results
DEFA14A
PVCT
Provectus Biopharmaceuticals, Inc.
20 Jun 24
Additional proxy soliciting materials
6:03am
targets.
Information about the Company’s clinical trials can be found at the National Institutes of Health (NIH) registry, ClinicalTrials.gov
8-K
EX-99.1
PVCT
Provectus Biopharmaceuticals, Inc.
15 Feb 24
Provectus Biopharmaceuticals Announces First Quarter 2024 Conference Call
8:05am
regeneration and repair, and proprietary targets.
Information about the Company’s clinical trials can be found at the National Institutes of Health
DEFA14A
z1baeut7ymokp8ap3s9
26 May 22
Additional proxy soliciting materials
1:26pm
DEFA14A
ra0g1 5ag16ss8r
19 May 22
Additional proxy soliciting materials
6:15am
8-K
EX-99.1
5h11z 34v58h2
19 Apr 22
Other Events
4:31pm
8-K
EX-99.1
osgjiecv ab
10 Nov 14
Provectus Biopharmaceuticals PV-10 Data Presented at Sitc 29TH Annual Meeting
12:00am
8-K
EX-99.1
wqoy5
12 Jun 14
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
hn2no3z
3 Jun 14
Regulation FD Disclosure
12:00am
8-K
EX-99.1
rx4xac07
21 May 14
Regulation FD Disclosure
12:00am
8-K
EX-99.1
3bok3guq
24 Mar 14
Provectus Biopharmaceuticals Inc. Submits Application to Fda to Receive Breakthrough Therapy Designation for PV-10 for Treatment of Melanoma
12:00am